US2019224361A1PendingUtilityA1

Compositions and methods for multipurpose disinfection and sterilization solutions

Assignee: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUNDPriority: Sep 3, 2015Filed: Jan 24, 2019Published: Jul 25, 2019
Est. expirySep 3, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61L 2/18A61L 2103/15A01N 33/12A61L 12/143A61L 12/142A61L 12/145A61L 12/10A61L 12/102A01N 59/00A61L 2103/05A61L 2/0088A61L 2202/24
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure discloses compositions and methods for multipurpose disinfection and sterilization solutions broadly effective against multiple microbial pathogens. The present disclosure demonstrates broad spectrum antimicrobial activity against environmental and pathogenic amoeba, bacterial spores, vegetative bacteria, fungi, rickettsia, viruses, parasites and toxic microbial products. The multipurpose disinfection solutions of the present disclosure may be used alone or in combination for a variety of purposes, including disinfection of medical devices such as contact lenses, contact lens cases, surgical instruments, and dental instruments.

Claims

exact text as granted — not AI-modified
1 . A medical disinfecting composition comprising:
 (a) a chlorite salt;   (b) a quaternary ammonium salt, wherein the quaternary ammonium salt is C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride;   (c) ammonium chloride having a formula of NH 4 Cl; and   (d) water.   
     
     
         2 . The medical disinfecting composition of  claim 1 , wherein the chlorite salt is an alkali metal chlorite salt. 
     
     
         3 . The medical disinfecting composition of  claim 2 , wherein the alkali metal chlorite salt is sodium chlorite. 
     
     
         4 . The medical disinfecting composition of  claim 3 , wherein the sodium chlorite is present in an amount ranging from about 0.0001% to about 0.1% (w/w). 
     
     
         5 . The medical disinfecting composition of  claim 3 , wherein the sodium chlorite is provided as a stabilized chlorine dioxide solution. 
     
     
         6 . The medical disinfecting composition of  claim 5 , wherein the stabilized chlorine dioxide is present in an amount ranging from about 0.005% to about 1.0% (w/w). 
     
     
         7 . The medical disinfecting composition of  claim 5 , wherein the stabilized chlorine dioxide solution comprises chlorine dioxide. 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . The medical disinfecting composition of  claim 1 , wherein the C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride is present in an amount ranging from about 0.00005% to about 0.1% (w/w). 
     
     
         12 . The medical disinfecting composition of  claim 11 , wherein the C12-C14-alkyl(ethylbenzyl)dimethylammonium chloride is present in an amount ranging from about 0.001% to about 0.1% (w/w). 
     
     
         13 . The medical disinfecting composition of  claim 1 , wherein the ammonium chloride is present in an amount ranging from about 0.001% to about 2.0% (w/w). 
     
     
         14 . The medical disinfecting composition of  claim 1 , further comprising a buffer to maintain the pH between about 7 and about 8. 
     
     
         15 . The medical disinfecting composition of  claim 14 , wherein the pH is about 7. 
     
     
         16 .- 30 . (canceled)

Join the waitlist — get patent alerts

Track US2019224361A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.